MEDICAL RECORD 
CONTINUATION SHEET lor either 
n!h If 111 ’ P,° nSe o '° P ? rtici P ate A Clinical Research Study 
NIH 2514-2, Minor Patient s Ascent to Participate In A Clinical Research Study 
STUDY NUMBER: 
CONTINUATION: page!2_ot 14 
may greatly further the understanding of the best method to 
successfully fight and cure cancer. We cannot, however, 
guarantee that you will receive any of these benefits and at this 
time the likelihood of these benefits is difficult to estimate 
given the low number of patients treated with this type of 
therapy, and the long duration of follow-up necessary to assess 
cure . 
Alternatives to this Study 
As discussed in the beginning of this consent form, the only 
alternative therapy available that has been proven to offer 
potential cure is allogeneic bone marrow transplantation 
(transplantation of bone marrow from another person). Either 
because of your age or lack of a suitable donor, you and your 
doctor have decided against this option. You could elect to be 
treated with conventional oral chemotherapy such as hydroxyurea 
while in chronic phase and receive no aggressive chemotherapy 
until blast crisis occurs. This approach has not allowed 
patients to live more than several months beyond the beginning of 
blast crisis. You could also choose to be treated with 
interferon alone for control of chronic phase and elect not to go 
ahead with stem cell harvesting or transplantation, even if yo,u 
do not have a complete cytogenetic remission. 
You may choose to withdraw from this study at any time. 
Howeveir, withdrawal from the study after high-dose chemothfetapy 
and radiatiori without reinfusion of marrow and peripheral blood 
cells would dlmofet certainly result in death. 
IDENTIFICATION 
CONTINUATION SHEET for either: 
Recombinant DNA Research, Volume 16 
[191] 
